Negatively charged gold nanoclusters protect against diabetic cardiomyopathy by inhibiting mitophagy

Negatively charged AuNCs were found to stabilize the membrane potential and inhibit mitophagy, thereby preventing diabetic cardiomyopathy.

[1]  K. Varga,et al.  Catalytically potent and selective clusterzymes for modulation of neuroinflammation through single-atom substitutions , 2020, Nature Communications.

[2]  T. Dawson,et al.  PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease , 2020, Molecular Neurodegeneration.

[3]  S. Houser,et al.  Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control , 2018, Front. Physiol..

[4]  Tsung-Rong Kuo,et al.  Biomedical Applications for Gold Nanoclusters: Recent Developments and Future Perspectives , 2018, Nanoscale Research Letters.

[5]  S. Sollott,et al.  Mitochondrial membrane potential. , 2017, Analytical biochemistry.

[6]  R. Jin,et al.  Evolution from the plasmon to exciton state in ligand-protected atomically precise gold nanoparticles , 2016, Nature Communications.

[7]  Hao Xu,et al.  PINK1-Parkin-Mediated Mitophagy Protects Mitochondrial Integrity and Prevents Metabolic Stress-Induced Endothelial Injury , 2015, PloS one.

[8]  G. Lopaschuk,et al.  Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy , 2014, British journal of pharmacology.

[9]  J. Enkovaara,et al.  Birth of the localized surface plasmon resonance in monolayer-protected gold nanoclusters. , 2013, ACS nano.

[10]  P. Schulze,et al.  Lipid metabolism and toxicity in the heart. , 2012, Cell metabolism.

[11]  U. Kompella,et al.  Functionalized nanosystems for targeted mitochondrial delivery. , 2012, Mitochondrion.

[12]  Atsushi Tanaka,et al.  PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin , 2010, PLoS biology.

[13]  W. Lederer,et al.  Probing the outer mitochondrial membrane in cardiac mitochondria with nanoparticles. , 2007, Biophysical journal.

[14]  Thomas H Marwick,et al.  Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. , 2004, Endocrine reviews.

[15]  J. Sowers,et al.  Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease , 2017, Diabetologia.